Abstract
Aspergillus funiculosus NCIM 1029 has been reported for the production of kojic acid exhibiting antibacterial, antifungal and larvicidal activity against 3rd instar larvae of Aedes aegypti.
Aim of the Study: To check the antifeedant, acute toxicity and sublethal growth effects of fungal metabolite, kojic acid against the agriculture pest, Spodoptera litura.
Materials and Methods: Kojic acid was checked for feeding deterrence activity against 4th instar larvae of S. litura in comparison to insect antifeedant, azadirachtin. Reduction in the weight and length of the larvae was evaluated after three days of exposure to kojic acid (400μg/ml). The effect of kojic acid on pupation and adult emergence was also studied.
Results: On determination of feeding deterrence, the DC50 value for kojic acid was found to be 180.645 ± 6.35μg/ml on comparison to azadirachtin (DC50 = 41.372 ± 2.21). The LD50 & LD90 values of kojic acid were found to be 693.52± 51.31 and 1889.13 ± 279.03μg/ml, respectively. The reduction in larval weight and length were 83.24 and 87.50%, respectively. The percentage pupation and adult emergence were reduced by 69% and 64% for the exposed larvae.
Conclusions: Kojic acid showed moderate feeding deterrence, acute toxicity and sublethal growth effects against S. litura.
Keywords: Aspergillus funiculosus, kojic acid, Spodoptera litura, acute toxicity, antifeedant.
The Natural Products Journal
Title:Feeding Deterrence, Acute Toxicity and Sublethal Growth Effects of Kojic Acid Isolated from Aspergillus funiculosus
Volume: 4 Issue: 1
Author(s): Siddhardha Busi, Jobina Rajkumari and Sairengpuii Hnamte
Affiliation:
Keywords: Aspergillus funiculosus, kojic acid, Spodoptera litura, acute toxicity, antifeedant.
Abstract: Aspergillus funiculosus NCIM 1029 has been reported for the production of kojic acid exhibiting antibacterial, antifungal and larvicidal activity against 3rd instar larvae of Aedes aegypti.
Aim of the Study: To check the antifeedant, acute toxicity and sublethal growth effects of fungal metabolite, kojic acid against the agriculture pest, Spodoptera litura.
Materials and Methods: Kojic acid was checked for feeding deterrence activity against 4th instar larvae of S. litura in comparison to insect antifeedant, azadirachtin. Reduction in the weight and length of the larvae was evaluated after three days of exposure to kojic acid (400μg/ml). The effect of kojic acid on pupation and adult emergence was also studied.
Results: On determination of feeding deterrence, the DC50 value for kojic acid was found to be 180.645 ± 6.35μg/ml on comparison to azadirachtin (DC50 = 41.372 ± 2.21). The LD50 & LD90 values of kojic acid were found to be 693.52± 51.31 and 1889.13 ± 279.03μg/ml, respectively. The reduction in larval weight and length were 83.24 and 87.50%, respectively. The percentage pupation and adult emergence were reduced by 69% and 64% for the exposed larvae.
Conclusions: Kojic acid showed moderate feeding deterrence, acute toxicity and sublethal growth effects against S. litura.
Export Options
About this article
Cite this article as:
Busi Siddhardha, Rajkumari Jobina and Hnamte Sairengpuii, Feeding Deterrence, Acute Toxicity and Sublethal Growth Effects of Kojic Acid Isolated from Aspergillus funiculosus, The Natural Products Journal 2014; 4 (1) . https://dx.doi.org/10.2174/2210315504666140515004643
DOI https://dx.doi.org/10.2174/2210315504666140515004643 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tau Protein Phosphorylation as a Therapeutic Target in Alzheimers Disease
Current Topics in Medicinal Chemistry Common SAR Derived from Linear and Non-linear QSAR Studies on AChE Inhibitors used in the Treatment of Alzheimer's Disease
Current Neuropharmacology Understanding the Potential Role and Delivery Approaches of Nitric Oxide in Chronic Wound Healing Management
Current Pharmaceutical Design Genetic and Epigenetic Heterogeneity in Cancer: The Ultimate Challenge for Drug Therapy
Current Drug Targets An Overview of Notch Signaling in Adult Tissue Renewal and Maintenance
Current Alzheimer Research Methylphenidate (Ritalin): What Makes it so Widely Prescribed During the Last 60 Years?
Current Drug Therapy Meet Our Co-Editor
Central Nervous System Agents in Medicinal Chemistry Therapeutic Outlook of Pyrazole Analogs: A Mini Review
Mini-Reviews in Medicinal Chemistry Mood Disorders in Elderly Population: Neurostimulative Treatment Possibilities
Recent Patents on CNS Drug Discovery (Discontinued) Astrocytes Exert and Control Immune Responses in the Brain
Current Immunology Reviews (Discontinued) Human Endotoxemia as a Model of Systemic Inflammation
Current Medicinal Chemistry Repurposing Pharmaceuticals as Neuroprotective Agents for Cerebral Malaria
Current Clinical Pharmacology Inhibition of Tau Aggregation in Cell Models of Tauopathy
Current Alzheimer Research Computational Methods and Algorithms for Mass Spectrometry Based Differential Proteomics: Recent Advances, Perspectives and Open Problems
Current Proteomics Managing Acute Agitation and Psychotic Symptoms in the Emergency Department
Adolescent Psychiatry A Sensitive HPLC-MS/MS Method for the Quantification of Selegiline in Beagle Dog Plasma: Application to a Pharmacokinetic Study
Current Pharmaceutical Analysis Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
Current Drug Therapy Ontologies in Medicinal Chemistry: Current Status and Future Challenges
Current Topics in Medicinal Chemistry Understanding the Molecular Mechanism of Sigma-1 Receptors: Towards A Hypothesis that Sigma-1 Receptors are Intracellular Amplifiers for Signal Transduction
Current Medicinal Chemistry The Male Abnormal Gene Family 21 (Mab21) Members Regulate Eye Development
Current Molecular Medicine